The landscape of diversity, equity, and inclusion (DEI) in healthcare is undergoing a seismic shift following recent executive orders (EO) issued by President Donald J. Trump. The order, titled "Ending Illegal Discrimination and Restoring Merit-Based Opportunity," aims to eliminate DEI initiatives within federal government agencies and private companies contracting with the government. This policy shift presents significant legal and operational challenges for healthcare providers, particularly those relying on federal funding.
The Trump Administration and DEI
On March 7, the Department of Health and Human Services (HHS) announced that it is investigating four unnamed medical schools and hospital systems for employment discrimination. These investigations are related to allegations received by the HHS Office of Civil Rights (OCR) that certain medical schools and hospitals receiving HHS funding “may operate medical education, training, or scholarship programs for current or prospective workforce members that discriminate on the basis of race, color, national origin, or sex.”
Since taking office, President Trump has issued multiple executive orders aimed at dismantling DEI initiatives across the federal government and targeting DEI programs in the private sector. These include:
What constitutes an “illegal” DEI program or policy?
EO 14173 does not define what constitutes a DEI program or what the government believes may be an “illegal” DEI program. Instead, EO 14173 indicates that “preferences” and “workforce balancing” based on race, gender, and other protected characteristics are unlawful. It is unclear whether the Trump administration will issue guidance to clarify EO 14173.
Heightened FCA Scrutiny for Healthcare Providers
The False Claims Act remains a formidable tool for enforcing compliance in federal contracts. In 2024, federal authorities secured over $2.9 billion in FCA settlements and judgments.
Key concerns under the new executive orders include:
Impact on Healthcare Providers and Federal Contractors
Hospitals and other health systems have long embraced DEI principles, viewing them as vital to improving
The federal government provides significant funding to hospitals and other provider networks through Medicare and Medicaid reimbursement, which raises concerns that hospitals may be subject to the executive order's mandates. EO 14173 explicitly names the medical industry as one that has "adopted and actively [used] dangerous, demeaning, and immoral race- and sex-based preferences under the guise of so-called 'diversity, equity, and inclusion' (DEI)." Many leading medical associations have countered this stance, arguing that DEI initiatives are essential to address systemic healthcare disparities and to improve patient outcomes.
Some of President Trump’s actions apply only to the federal government, but several of his executive orders impact the private sector. EO 14173, for example, applies to all companies in the private sector and has additional implications and requirements for federal contractors and grantees. Federal contractors are no longer required to create affirmative action plans for females and minorities. Additionally, it requires all agencies to include the following language in every federal contract and grant:
FCA investigations are always areas of concern for healthcare entities even when the entity is unaware of any violation; these investigations are intrusive, time-consuming, burdensome, and expensive. EO 14173 directs the DOJ to investigate and penalize DEI initiatives in the private sector, including potential civil and criminal investigations under the FCA. This executive order instructs the U.S. Attorney General to prepare a strategic enforcement plan to target and end illegal discrimination and preferences, including DEI.
Specifically, the EO directs DOJ to prepare a report detailing specific strategies to “encourage the private sector to end illegal DEI discrimination and preferences and comply with all Federal civil-rights laws,” including requiring each of the over 400 federal agencies to identify “[u]p to nine potential civil compliance investigations of publicly traded corporations, large non-profit corporations or associations, foundations with assets of 500 million dollars or more, State and local bar and medical associations, and institutions of higher education with endowments over 1 billion dollars.”
Many hospitals and healthcare systems may find themselves the target of such an investigation. Key actions for healthcare providers impacted by EO 14173 and the other new executive orders include:
The Road Ahead: Navigating Corporate Diversity Values in this New Framework
These new executive orders represent a fundamental shift in federal policy regarding DEI. However, many healthcare leaders and providers remain committed to the principle that diversity and inclusion contribute to better patient care and improved health outcomes.
Even more unsettling because of these executive orders is the concern that programs designed to address healthcare disparities in underserved and underrepresented populations may be seen as DEI policies with false claims implications. While the current executive orders seem tailored towards employment and workforce policies, the anti-DEI movement may broaden the impact on healthcare systems and providers.
As legal challenges and further regulatory clarifications emerge, healthcare providers must stay vigilant. Partnering with the experienced healthcare attorneys at McBrayer to proactively assess legal risks will be essential to navigating this new era for every impacted organization. The coming months will determine how these changes reshape the healthcare sector’s approach to DEI and its broader mission of access to equitable and compassionate patient care.
Services may be performed by others. This article does not constitute legal advice.